
Release date: 2026-02-04 17:17:56 Article From: Lucius Laos Recommended: 4
The most common side effects of pirfenidone include upper respiratory tract infection, fatigue, headache, dizziness, decreased appetite, sinusitis, insomnia, and weight loss.
Pirfenidone may cause serious side effects, including:
Inform your doctor immediately if you experience any of the following symptoms: yellowing of the skin or whites of the eyes, dark or brown-colored urine (e.g., tea-colored), pain in the right upper abdomen, increased bleeding or bruising than usual, or unusual fatigue. Your doctor will also perform regular blood tests to monitor your liver function.
When outdoors, apply sunscreen with a sun protection factor (SPF) of 50 or higher, and wear hats and clothing that cover your skin to prevent sunburn.
Contact your doctor right away if you develop severe skin reactions, such as skin blisters, rashes, oral ulcers, urticaria, or any other serious skin symptoms.
Pirfenidone may cause gastrointestinal discomfort, such as nausea, vomiting, diarrhea, dyspepsia, heartburn, and abdominal pain.
If side effects persist, your doctor may adjust your dosage or discontinue pirfenidone treatment.
These are not all the possible side effects of pirfenidone.
Idiopathic pulmonary fibrosis is a progressive disease, so one of the key goals of treatment is to slow its progression.
Following your doctor’s instructions to start and adhere to pirfenidone treatment is an important way to help slow disease progression and thereby preserve your existing lung function as much as possible.
Studies have shown that pirfenidone helps maintain lung function. Therefore, you may not "feel" any difference after starting treatment, as it is not used to relieve the symptoms of idiopathic pulmonary fibrosis and cannot reverse existing lung scarring.
The rate of disease progression varies among patients with idiopathic pulmonary fibrosis. Lung function may continue to decline whether or not you take pirfenidone. Remember, the goal of treatment is to slow this decline. Your doctor will perform long-term lung function tests to monitor the impact of idiopathic pulmonary fibrosis on your lungs.
The recommended full daily dosage of pirfenidone is 3 tablets (267 mg yellow tablets) per dose, three times a day, taken with meals.
In addition, an alternative dosage regimen with fewer tablets per day is available.
The daily dosage should be taken with meals at fixed times: breakfast, lunch, and dinner.
If you miss a dose, take it with a meal as soon as you remember.
Do not take two doses at one time to make up for a missed dose.
The daily dosage should not exceed three times a day.
In case of an overdose, contact your doctor immediately or go to the emergency department of the nearest hospital.
Taking pirfenidone with meals or immediately after a meal may help reduce certain side effects.
If you experience side effects, consult your healthcare provider. They may need to lower your dosage or advise you to temporarily pause treatment to help alleviate the side effects.
You should always take pirfenidone with meals. Doing so may help reduce certain side effects, including dizziness or nausea. Taking it with food slows the absorption rate of pirfenidone and reduces its plasma concentration.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:832025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:3752024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended:742025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended:952025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended:902025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended:1052025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended:1032025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended:1002025-27-11

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: